U.S. Healthcare IT Software Market
完整報告名稱與涵蓋範圍
U.S. Healthcare IT Software Market Size, Share & Trends Analysis Report By Software Type (Revenue Cycle Management Software, Tele-healthcare Software, eClinical Software, Cloud-based EHR & EMR Software) And Segment Forecasts, 2026 - 2033
報告摘要
U.S. Healthcare IT Software Market Summary
The U.S. healthcare IT software market size was valued at USD 189.6 billion in 2025 and is projected to grow from USD 216.5 billion in 2026 to USD 634.0 billion by 2033, at a CAGR of 16.6% from 2026 to 2033. The increasing adoption of electronic health records (EHRs) and electronic medical records (EMRs), fueled by federal mandates and initiatives such as the HITECH Act, has significantly expanded the market. Rising demand for interoperability, a shift towards value-based care, and population health management have further accelerated the adoption of healthcare analytics software.
U.S. Healthcare IT Software Market Segmentation
This report forecasts revenue growth at the country levels and provides an analysis of industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare IT software market on the basis of software type.
• Software Type Outlook (Revenue, USD Million, 2021 - 2033)
• Revenue Cycle Management Software
o Integrated
o Standalone
• Tele-healthcare Software
o Tele-care
o Activity Monitoring
o Remote Medication Management
o Tele-Health
o LTC Monitoring
o Video Consultation
• Population Health Management (PHM) Software
• Cloud-based EHR & EMR Software
• Clinical Information Software
• Technology Solutions in the Healthcare Payers Software
o Claims Management
o Enrollment and Member Management
o Provider Management
o Revenue Management and Billing
o Analytics
o Value based Payments
o Data management and support
o Personalize/CRM
o Clinical Decision Support
o Others
• Healthcare Customer Relationship Management (CRM) Software
o Sales
o Customer Service and Support
o Marketing
o Digital Commerce
o Cross -CRM
• eClinical Software
o Clinical Trial Management System (CTMS)
o Electronic Clinical Outcome Assessment (eCOA)
o Electronic Data Capture (EDC) & CDMS
o Clinical Data Integration Platforms
o Clinical Analytics Platforms
o Safety Solutions
o Electronic Trial Master File (eTMF)
o Randomization and Trial Supply Management (RTSM)
o eConsent
• Healthcare Analytics Software
o Descriptive Analytics
o Diagnostic Analytics
o Predictive Analytics
o Prescriptive Analytics
• Medical Imaging Information Software
o Radiology Information Software
o Monitoring Analysis Software
o Picture Archiving and Communication Software
• Electronic Prescribing Software (E-Prescribing Solutions)
• Computerized Provider Order Entry Software
• Laboratory Information Software
• Digital Healthcare Supply Chain Management Software
授權報價
| Single User License | $3,950 USD |
| Enterprise License | $4,950 USD |
| Corporate User License | $6,950 USD |
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Software Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Widespread Adoption of Electronic Health Records (EHR) and Electronic Medical Records (EMR)
3.2.1.2. Growing demand for remote patient monitoring for improved out-of- hospital care
3.2.1.3. Technologically advanced healthcare IT infrastructure
3.2.1.4. Increase in the number of initiatives and investments supporting eHealth and digital health
3.2.1.5. Rise in healthcare expenditure prompting cost-cutting initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of data privacy
3.2.2.2. Lack of medical expertise
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.3. Regulatory Overview
3.3.1. HIPAA Compliance Landscape
3.3.2. ONC Interoperability & Information Blocking Rules (21st Century Cures Act)
3.3.3. CMS Reimbursement Policy Impact
3.3.4. FDA Regulations (for SaMD / AI-based clinical tools)
3.4. Technology Overview
3.4.1. Computerized Provider Order Entry Systems
3.4.2. Electronic Prescribing Systems (E-Prescribing Solutions)
3.4.3. Laboratory Information
3.4.4. Clinical Information Systems
3.4.5. Medical Imaging Information Systems
3.4.6. Tele-healthcare
3.4.7. Revenue Cycle Management
3.4.8. eClinical Solutions
3.4.9. Population Health Management (PHM)
3.4.10. Digital Healthcare Supply Chain Management
3.4.11. Healthcare Customer Relationship Management (CRM)
3.4.12. Technology Solutions in Healthcare Payers
3.4.13. Healthcare Analytics
3.5. U.S. Healthcare IT Software Industry- Case Study Insights
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.1.1. Supplier power
3.6.1.2. Buyer power
3.6.1.3. Substitution threat
3.6.1.4. Threat of new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic and Social landscape
3.6.2.3. Technological landscape
3.6.2.4. Environmental landscape
3.6.2.5. Legal Landscape
Chapter 4. U.S. Healthcare IT Software Market: Software Type Estimates & Trend Analysis
4.1. Software Type Segment Dashboard
4.2. Software Type Market Share Movement Analysis, 2025 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Software Type, 2021 to 2033 (USD Million)
4.4. Computerized Provider Order Entry Systems
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Electronic Prescribing Systems (E-Prescribing Solutions)
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Laboratory Information
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Clinical Information Systems
4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Medical Imaging Information Systems
4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.2. Radiology Information Systems
4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.3. Monitoring Analysis Software
4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.4. Picture Archiving and Communication Systems
4.8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Tele-healthcare
4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9.2. Tele-care
4.9.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9.3. Tele-Health
4.9.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Revenue Cycle Management
4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10.2. Integrated
4.10.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10.3. Standalone
4.10.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11. eClinical Solutions
4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.2. Electronic Clinical Outcome Assessment (eCOA)
4.11.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.3. Electronic Data Capture (EDC) & CDMS
4.11.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.4. Clinical Analytics Platforms
4.11.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.5. Clinical Data Integration Platforms
4.11.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.6. Safety Solutions
4.11.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.7. Clinical Trial Management System (CTMS)
4.11.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.8. Randomization and Trial Supply Management (RTSM)
4.11.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.9. Electronic Trial Master File (eTMF)
4.11.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11.10. eConsent
4.11.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.12. Population Health Management (PHM)
4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.13. Digital Healthcare Supply Chain Management
4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14. Healthcare Customer Relationship Management (CRM)
4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14.2. Customer Service and Support
4.14.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14.3. Digital Commerce
4.14.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14.4. Marketing
4.14.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14.5. Sales
4.14.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.14.6. Cross –CRM
4.14.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15. Technology Solutions in the Healthcare Payers
4.15.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.2. Enrollment and Member Management
4.15.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.3. Provider Management
4.15.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.4. Claims Management
4.15.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.5. Value based Payments
4.15.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.6. Revenue Management and Billing
4.15.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.7. Analytics
4.15.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.8. Personalize/CRM
4.15.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.9. Clinical Decision Support
4.15.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.10. Data management and support
4.15.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.15.11. Others
4.15.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.16. Healthcare Analytics
4.16.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.16.2. Descriptive Analysis
4.16.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.16.3. Predictive Analysis
4.16.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.16.4. Prescriptive Analysis
4.16.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Competitive Landscape
5.1. Participant Overview
5.2. Company Market Position Analysis
5.3. Company Categorization
5.4. Company Profiles/Listing
5.4.1. Koninklijke Philips N.V.
5.4.1.1. Overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. McKesson Corporation
5.4.2.1. Overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. eMDs, Inc.
5.4.3.1. Overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.)
5.4.4.1. Overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Athenahealth, Inc. (Acquired by Hellman & Friedman and Bain Capital)
5.4.5.1. Overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Carestream Health
5.4.6.1. Overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. GE Healthcare
5.4.7.1. Overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Agfa- Gevaert Group
5.4.8.1. Overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Hewlett Packard Enterprise Development LP
5.4.9.1. Overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Novarad
5.4.10.1. Overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
5.4.11. Optum, Inc.
5.4.11.1. Overview
5.4.11.2. Financial performance
5.4.11.3. Product benchmarking
5.4.11.4. Strategic initiatives
5.4.12. IBM
5.4.12.1. Overview
5.4.12.2. Financial performance
5.4.12.3. Product benchmarking
5.4.12.4. Strategic initiatives
5.4.13. Oracle
5.4.13.1. Overview
5.4.13.2. Financial performance
5.4.13.3. Product benchmarking
5.4.13.4. Strategic initiatives
5.4.14. SAS Institute, Inc.
5.4.14.1. Overview
5.4.14.2. Financial performance
5.4.14.3. Product benchmarking
5.4.14.4. Strategic initiatives
5.4.15. IQVIA
5.4.15.1. Overview
5.4.15.2. Financial performance
5.4.15.3. Product benchmarking
5.4.15.4. Strategic initiatives
5.4.16. Verisk Analytics, Inc.
5.4.16.1. Overview
5.4.16.2. Financial performance
5.4.16.3. Product benchmarking
5.4.16.4. Strategic initiatives
5.4.17. SAP
5.4.17.1. Overview
5.4.17.2. Financial performance
5.4.17.3. Product benchmarking
5.4.17.4. Strategic initiatives
5.4.18. Accenture
5.4.18.1. Overview
5.4.18.2. Financial performance
5.4.18.3. Product benchmarking
5.4.18.4. Strategic initiatives
圖表清單 List of Tables & Figures
List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 World Index of Healthcare Innovation
TABLE 3 Smartphone penetration, by key country, 2025
TABLE 4 Venture capitalist funding in different healthcare sectors (USD Million)
TABLE 5 U.S. healthcare IT early- and late-stage VC and growth deals
TABLE 6 U.S. Healthcare IT Software market, by Software Type, 2021 - 2033 (USD Million)
List of Figures
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 U.S. Healthcare IT Software Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Key market opportunities prioritized
FIG. 12 PESTLE Analysis
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 EHR percentage adoption in the U.S.
FIG. 15 U.S. Healthcare IT Software market: Software Type outlook key takeaways
FIG. 16 U.S. Healthcare IT Software market: Software Type movement analysis
FIG. 17 U.S. Electronic Health Records market, 2021 - 2033 (USD Million)
FIG. 18 U.S. Computerized Provider Order Entry Systems market, 2021 - 2033 (USD Million)
FIG. 19 U.S. Electronic Prescribing Systems market, 2021 - 2033 (USD Million)
FIG. 20 U.S. Medical Imaging Information Systems market, 2021 - 2033 (USD Million)
FIG. 21 U.S. Laboratory Informatics market, 2021 - 2033 (USD Million)
FIG. 22 U.S. Clinical Information Systems market, 2021 - 2033 (USD Million)
FIG. 23 U.S. Tele-healthcare market, 2021 - 2033 (USD Million)
FIG. 24 U.S. Revenue Cycle Management market, 2021 - 2033 (USD Million)
FIG. 25 U.S. eClinical Solutions market, 2021 - 2033 (USD Million)
FIG. 26 U.S. Population Health Management (PHM) market, 2021 - 2033 (USD Million)
FIG. 27 U.S. Digital Healthcare Supply Chain Management market, 2021 - 2033 (USD Million)
FIG. 28 U.S. Clinical Alarm Management market, 2021 - 2033 (USD Million)
FIG. 29 U.S. Healthcare Customer relationship management (CRM) market, 2021 - 2033 (USD Million)
FIG. 30 U.S. Technology Solutions in the Healthcare Payers market, 2021 - 2033 (USD Million)
FIG. 31 U.S. Healthcare Analytics market, 2021 - 2033 (USD Million)
FIG. 32 Strategy Mapping
FIG. 33 Key company market position analysis, 2025
FIG. 34 Key company market share analysis, 2025 (%)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們